2025-10-23 - Analysis Report
Okay, let's break down the analysis of Albemarle Corp (ALB) based on the provided data.

**Report**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** ALB
*   **Company:** Albemarle Corp
*   **Description:** Albemarle Corporation is a specialty chemicals company with leading positions in lithium, bromine specialties, and catalysts.

**Key Numbers:**

*   **ALB Cumulative Return:** -11.83%
*   **VOO Cumulative Return:** 99.09%
*   **Absolute Divergence:** -107.5
*   **Relative Divergence:** 4.2

**Analysis:**

ALB has significantly underperformed the S&P 500 (VOO) over the period. The absolute divergence of -107.5 indicates a substantial gap in returns.  The relative divergence of 4.2 suggests that ALB's performance is near the bottom end of its historical range compared to the S&P 500. It is in the lower 4.2% of the past data distribution range.

**Alpha, Beta, CAGR, MDD Analysis**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2015-2017  | 85.0%   | 68.0%   | 56.0%   | 0.1   | 15.3   |
| 2016-2018  | 9.0%    | 68.0%   | -6.0%   | 0.0   | 9.2    |
| 2017-2019  | -44.0%  | 73.9%   | -66.0%  | 0.1   | 8.7    |
| 2018-2020  | 44.0%   | 79.4%   | 20.0%   | 0.2   | 17.6   |
| 2019-2021  | 149.0%  | 79.4%   | 103.0%  | -0.1  | 27.9   |
| 2020-2022  | 148.0%  | 79.9%   | 149.0%  | 0.5   | 25.9   |
| 2021-2023  | -26.0%  | 81.9%   | -27.0%  | 0.5   | 17.2   |
| 2022-2024  | -152.0% | 81.9%   | -172.0% | 0.3   | 10.3   |
| 2023-2025  | -233.0% | 81.9%   | -297.0% | -0.5  | 10.9   |

**Analysis:**

*   **CAGR (Compound Annual Growth Rate):**  Shows a highly volatile growth pattern, ranging from substantial positive growth (e.g., 149% in 2019-2021) to significant losses (e.g., -233% in 2023-2025). Recent years have seen sharp declines.
*   **MDD (Maximum Drawdown):** Consistently high MDD values indicate significant risk and volatility.
*   **Alpha:**  Represents excess return relative to the market.  Negative alpha values in recent periods indicate underperformance compared to the market.
*   **Beta:** Measures volatility relative to the market.  The beta values are generally low, implying less sensitivity to overall market movements, although the recent negative beta suggests possible inverse correlation.
*   **Cap(B):** Market capitalization fluctuates, reflecting investor sentiment and company performance.

**2. Recent Stock Price Movements**

*   **Current Price:** 91.34
*   **Last Market Data:** price: 91.27, previousClose: 91.34, change: -0.08
*   **5-day Moving Average:** 94.73
*   **20-day Moving Average:** 89.83
*   **60-day Moving Average:** 81.90

**Analysis:**

The current price is slightly below the previous close, showing a minor decrease. The 5-day moving average is above the current price and the 20-day moving average, suggesting a recent downward trend after a short-term peak. The 20-day moving average is above the 60-day moving average, but the current price is between them, indicating uncertainty in the medium-term trend.

**3. Market Risk Indicator (MRI) & Other Indicators**

*   **MRI:** 0.9 (High Investment Recommended)
*   **RSI:** 60.03
*   **PPO:** -0.07
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (12 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-10-01)
*   **Delta_Previous_Relative_Divergence:** -0.1 (Negative: Short-term Decline)
*   **Expected Return (%):** 699.7

**Analysis:**

*   **MRI (0.9):**  Despite the recent underperformance, the MRI suggests a *High Investment Recommended* rating. This might be based on a longer-term outlook or other factors not immediately apparent in the recent data.
*   **RSI (60.03):**  RSI is in a neutral zone, suggesting neither overbought nor oversold conditions.
*   **PPO (-0.07):** PPO is slightly negative, indicating the short-term moving average is slightly below the long-term moving average, reinforcing the downward trend seen in the price data.
*   **Hybrid Signal:** The signal recommends a full allocation of cash into ALB shares and a monthly investment, labeling it "Very Safe" despite the recent volatility and underperformance. This appears contradictory to other data points and should be viewed with skepticism.
*   **Delta_Previous_Relative_Divergence:** The negative value confirms the recent short-term decline relative to the benchmark.
*   **Expected Return (699.7%):**  A very high expected return suggests that the model anticipates significant future growth, potentially due to a recovery in lithium prices or other positive catalysts. This should be carefully scrutinized.

**4. Recent News & Significant Events**

*   **Earnings Preview (Barchart):** Upcoming earnings are a significant focus.
*   **Investor Attention (Zacks):** ALB is attracting investor attention.
*   **Rare Earth Boom (Oilprice.com):**  Broader trends in critical minerals are relevant.
*   **Stock Sinks (Zacks):** Negative short-term price action.
*   **Trump Stock Market Bingo (Investor's Business Daily):**  Potential policy impacts on miners.
*   **Deutsche Bank Price Target Adjustment:**  A price target increase to $95 from $74 suggests some analysts see upside.

**Analysis:**

The news headlines paint a mixed picture.  Upcoming earnings are a key event. Analyst target adjustments provide some optimism, but recent price declines and general market volatility are causes for concern. The broader context of rare earth and critical mineral trends is relevant to ALB's business.

**4-2. Analyst Opinions**

*   **Consensus:** Hold
*   **Mean Rating:** 2.72 (~Hold)
*   **Opinions:** 22
*   **Target Price (avg/high/low):** 92.92 / 200.00 / 58.00
*   **Recent Rating Changes:** Not specified

**Analysis:**

The analyst consensus is "Hold," suggesting a neutral outlook. The average price target is slightly above the current price, indicating modest upside potential.  The wide range between the high and low price targets reflects significant uncertainty about the company's future prospects.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출       |
|------------|--------|------------|
| 2025-08-04 | -0.16  | 1.33 B$    |
| 2025-04-30 | 0      | 1.08 B$    |
| 2024-11-06 | -9.45  | 1.35 B$    |
| 2024-07-31 | -1.96  | 1.43 B$    |
| 2025-08-04 | -1.96  | 1.43 B$    |

**Analysis:**

The recent earnings data reveals inconsistent performance. There are fluctuating revenue and a negative EPS over the last periods

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-06-30   | $1.33B  | 14.80%        |
| 2025-03-31   | $1.08B  | 14.51%        |
| 2024-12-31   | $1.23B  | 11.22%        |
| 2024-09-30   | $1.35B  | -7.68%        |
| 2024-06-30   | $1.43B  | -0.74%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-06-30   | $10.24B   | 0.22%     |
| 2025-03-31   | $10.03B   | 0.41%     |
| 2024-12-31   | $9.96B    | 0.76%     |
| 2024-09-30   | $10.24B   | -10.44%   |
| 2024-06-30   | $11.22B   | -1.68%    |

**Analysis:**

*   **Revenue:** Revenue has fluctuated over the past few quarters, with some decline.
*   **Profit Margin:** Profit margins have been volatile, even dipping into negative territory.
*   **Equity:** Equity has remained relatively stable around $10 billion.
*   **ROE (Return on Equity):** ROE has also been volatile, with negative values indicating poor profitability.

**7. Overall Summary**

Albemarle (ALB) presents a mixed investment picture.

*   **Negative Factors:** Significant underperformance compared to the S&P 500, volatile earnings and profit margins, negative short-term price momentum, and analyst consensus "Hold" rating with significant uncertainty. Recent news also suggests negative short-term price action.
*   **Potentially Positive Factors:** High MRI suggesting a "High Investment Recommended" rating (contradictory), analyst price target adjustments suggesting potential upside, and a very high "Expected Return" (which should be viewed skeptically).

**Conclusion:**

Based on the available data, a cautious approach to Albemarle (ALB) is warranted.  The company faces significant challenges, including underperformance, volatile earnings, and a declining stock price. While some indicators suggest potential upside, these should be carefully scrutinized.  Investors should conduct further research and consider their risk tolerance before making any investment decisions. Pay close attention to the upcoming earnings report.
